MS Drug Cancer Link Rebuffed Highlights Specialty Pharmacy Week in Review

Top stories of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/ms-drug-cancer-link-rebuffed-highlights-specialty-" target="_blank">View the story "MS Drug Cancer Link Rebuffed Highlights Specialty Pharmacy Week in Review" on Storify</a>]

Related Content:

Specialty Pharmacy
Updates in Prevention, Treatment of Cytokine Release Syndrome, Neurologic Toxicities for Patients With Multiple Myeloma
Study: Ibrutinib Effective Treatment for Difficult to Treat Forms of Hairy Cell Leukemia
FDA Grants Orphan Drug Designation to Tesomet In Hypothalamic Obesity